Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study

Cancer Patients ◽

Term Survival ◽

Long Term Survival ◽

Danish Study

Long-term survival analysis of breast cancer patients treated with neoadjuvant chemotherapy

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2016.02.059 ◽

2016 ◽

Vol 42 (5) ◽

pp. S13

Author(s):

Asma Munir ◽

Sujatha Udayasankar ◽

Anita Huws ◽

Gill Dazeley ◽

Yousef Sharaiha ◽

...

Keyword(s):

Breast Cancer ◽

Survival Analysis ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Term Survival ◽

Abstract GMM-057: A FUNCTIONAL HOMOLOGOUS RECOMBINATION ASSAY PREDICTS PRIMARY CHEMOTHERAPY RESPONSE AND LONG-TERM SURVIVAL IN OVARIAN CANCER PATIENTS

10.1158/1557-3265.ovcasymp18-gmm-057 ◽

2019 ◽

Author(s):

Manuela Tumiati ◽

Sakari Hietanen ◽

Johanna Hynninen ◽

Elina Pietilä ◽

Anniina Färkkilä ◽

...

Keyword(s):

Ovarian Cancer ◽

Homologous Recombination ◽

Cancer Patients ◽

Primary Chemotherapy ◽

Chemotherapy Response ◽

Term Survival ◽

Long Term Survival ◽

Recombination Assay

Long-term Survival Advantage for Recurrent Ovarian Cancer Patients Receiving Pegylated Liposomal Doxorubicin

Oncology & Hematology Review (US) ◽

10.17925/ohr.2005.00.00.83 ◽

2005 ◽

Vol 00 (00) ◽

pp. 83

Author(s):

Alan N Gordon ◽

Keyword(s):

Ovarian Cancer ◽

Cancer Patients ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Recurrent Ovarian Cancer ◽

Survival Advantage ◽

Term Survival ◽

Comment on “Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery”

Annals of Surgery ◽

10.1097/sla.0000000000004606 ◽

2020 ◽

Vol Publish Ahead of Print ◽

Author(s):

Donglai Chen ◽

Junmiao Wen ◽

Yujia Zheng ◽

Yongbing Chen ◽

Chunlei Dai

Keyword(s):

Esophageal Cancer ◽

Lymph Nodes ◽

Cancer Patients ◽

Term Survival ◽

Long-term Survival Advantage for Recurrent Ovarian Cancer Patients Receiving Pegylated Liposomal Doxorubicin

European Oncology & Haematology ◽

10.17925/eoh.2005.0.0.83 ◽

2005 ◽

pp. 83

Author(s):

Alan N Gordon ◽

Keyword(s):

Ovarian Cancer ◽

Cancer Patients ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Recurrent Ovarian Cancer ◽

Survival Advantage ◽

Term Survival ◽

Abstract 1843: Surgical and chemotherapy influence on circulating developmental microRNA miR17-92 and long term survival in breast and ovarian cancer patients.

10.1158/1538-7445.am2013-1843 ◽

2013 ◽

Cited By ~ 1

Author(s):

Iuliana Shapira ◽

Annette Lee ◽

Michaela Oswald ◽

Janaki Parameswaran ◽

Keith Sultan ◽

...

Keyword(s):

Ovarian Cancer ◽

Cancer Patients ◽

Breast And Ovarian Cancer ◽

Term Survival ◽

Abstract 325: A functional homologous recombination assay predicts primary chemotherapy response and long-term survival in ovarian cancer patients

10.1158/1538-7445.am2018-325 ◽

2018 ◽

Author(s):

Manuela Tumiati ◽

Sakari Hietanen ◽

Johanna Hynninen ◽

Elina Pietilä ◽

Anniina Färkkilä ◽

...

Keyword(s):

Ovarian Cancer ◽

Homologous Recombination ◽

Cancer Patients ◽

Primary Chemotherapy ◽

Chemotherapy Response ◽

Term Survival ◽

Long Term Survival ◽

Recombination Assay

No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands

European Journal of Cancer ◽

10.1016/j.ejca.2017.10.030 ◽

2018 ◽

Vol 88 ◽

pp. 31-37 ◽

Cited By ~ 36

Author(s):

M. Timmermans ◽

G.S. Sonke ◽

K.K. Van de Vijver ◽

M.A. van der Aa ◽

R.F.P.M. Kruitwagen

Keyword(s):

Ovarian Cancer ◽

The Netherlands ◽

Epithelial Ovarian Cancer ◽

Cancer Patients ◽

Population Based ◽

Term Survival ◽

Population Based Study ◽

Comparison of Long-Term Survival Rates of Primary Surgery and Surgery After Neoadjuvant Chemotherapy in Ovarian Cancer

Istanbul Medical Journal ◽

10.4274/imj.galenos.2018.91297 ◽

2019 ◽

Author(s):

Alpaslan Kaban ◽

Samet Topuz ◽

Hamdullah Sözen ◽

Yavuz Salihoğlu

Keyword(s):

Ovarian Cancer ◽

Survival Rates ◽

Term Survival ◽

Long Term Survival ◽

Primary Surgery

Comparison of Long-Term Survival Rates of Primary Surgery and Surgery After Neoadjuvant Chemotherapy in Ovarian Cancer

Istanbul Medical Journal ◽

10.4274/imj.galenos.2019.91297 ◽

2019 ◽

Vol 20 (2) ◽

pp. 88-93

Author(s):

Alpaslan Kaban ◽

Samet Topuz ◽

Hamdullah Sözen ◽

Yavuz Salihoğlu

Keyword(s):

Ovarian Cancer ◽

Survival Rates ◽

Term Survival ◽

Long Term Survival ◽

Primary Surgery